Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
AVEO PHARMACEUTICALS, INC. (AVEO)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 13.0% | 12.1% | 11.6% | 26.8% | 11.5% | 10.9% | 7.2% | 0.0% |
| Gross profit | 87.0% | 87.9% | 88.4% | 73.2% | 88.5% | 89.1% | 92.8% | 100.0% |
| Selling, general and administrative | 57.7% | 67.5% | 82.9% | | 99.8% | 197.5% | 786.5% | |
| Research and development | 36.4% | 48.7% | 48.6% | 34.7% | 49.4% | 91.0% | 301.9% | 516.3% |
| General and administrative | | | | 88.7% | | | | 1016.7% |
| Depreciation | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | 0.9% | 1.4% |
| EBIT | -7.1% | -28.3% | -43.1% | -34.9% | -60.7% | -199.4% | -995.6% | -1985.8% |
| Pre-tax income | -10.7% | -32.9% | -48.8% | -41.1% | -68.3% | -179.9% | -1152.2% | -1298.4% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -10.7% | -32.9% | -48.8% | -41.1% | -68.3% | -179.9% | -1152.2% | -1298.4% |
|